Behavioral and anatomical abnormalities in a sodium iodate-induced model of retinal pigment epithelium degeneration

• Published in: Experimental eye research 2006-03, Vol.82 (3), p.441-448
• Main Authors: Enzmann, Volker, Row, Barry W., Yamauchi, Yasuyuki, Kheirandish, Leila, Gozal, David, Kaplan, Henry J., McCall, Maureen A.
• Format: Article
• Language: English
• Subjects: Animals; Cued water maze; Dose-Response Relationship, Drug; Histology; Injections, Intravenous; Iodates; Male; Mice; Mice, Inbred C57BL; Models, Animal; Pigment Epithelium of Eye - pathology; Retina - pathology; Retinal Degeneration - pathology; Retinal Degeneration - psychology; RPE; Sodium iodate; Time Factors; Vision, Ocular - drug effects
• ISSN: 0014-4835; 1096-0007
• DOI: 10.1016/j.exer.2005.08.002

We characterized changes in the visual behavior of mice in which a loss of the retinal pigment epithelium (RPE) was experimentally induced with intravenous (i.v.) administration of sodium iodate (NaIO 3). We compared and correlated these changes with alterations in neural retinal structure and function. RPE loss was induced in 4–6 week old male C57BL/6 mice with an i.v. injection of 1% NaIO 3 at three concentrations: 35, 50, or 70 mg/kg. At 1, 3, 7, 14, 21, and 28 days (d) as well as 6 months post injection (PI) a behavioral test was performed in previously trained mice to evaluate visual function. Eye morphology was then assessed for changes in both the RPE and neural retina. NaIO 3-induced RPE degeneration was both dose and PI time dependent. Our low dose showed no effects, while our high dose caused the most damage, as did longer PI times at our intermediate dose. Using the intermediate dose, no changes were detectable in either visual behavior or retinal morphology at 1 d PI. However, at 3 d PI visual behavior became abnormal and patchy RPE cell loss was observed. From 7 d PI onward, changes in retinal morphology and visual behavior became more severe. At 6 months PI, no recovery was seen in any of these measures in mice administered the intermediate dose. These results show that NaIO 3 dosage and/or time PI can be varied to produce different, yet permanent deficits in retinal morphology and visual function. Thus, this approach should provide a unique system in which the onset and severity of RPE damage, and its consequences can be manipulated. As such, it should be useful in the assessment of rescue or mitigating effects of retinal or stem cell transplantation on visual function.